Anja König
InvestorFounderGlobal Head of the Novartis Venture Fund at Novartis Venture Fund · Board director at Mediar Therapeutics
Basel, Switzerland
FoundedMediar Therapeutics
About
Anja Koenig, who holds a PhD in Physics from Cornell University, leads the Novartis Venture Fund and was previously a Managing Director at the fund covering Switzerland, the UK, the rest of Europe, and Asia/Pacific. Before joining NVF, she was an Associate Partner at McKinsey and Company in New York, working with healthcare companies across the US, Europe, and emerging markets. She is involved in the Swiss startup ecosystem and serves on the board of Sensirion, a publicly listed Swiss engineering company.
Invests in
BiotechHealthtech
Board director at Mediar Therapeutics
Intro paths
In turn, Anja can intro founders to Mediar Therapeutics's investors below.
Mediar Therapeutics's investors · 9
Co-founders at Mediar Therapeutics
Investments
Board seats
Sensirion
Investor
Arctos Medical AGBicycle TherapeuticsCovagen AGForendo PharmaGenedataHeptares Therapeutics, LtdNabriva TherapeuticsPharmAbcineQurient Therapeutics
Per the firm's website.
Colleagues at Novartis Venture Fund
Frequently asked questions
- Where does Anja König work?
- Anja König is Global Head of the Novartis Venture Fund at Novartis Venture Fund and Founder at Mediar Therapeutics.
- What does Anja König invest in?
- Anja König invests in Biotech, Healthtech.
- What companies did Anja König found?
- Anja König founded Mediar Therapeutics.